Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Cancer Immunology Research|May 5, 2017
RIG-I Resists Hypoxia-Induced Immunosuppression and DedifferentiationChristina Engel, Grethe Brügmann, Silke Lambing, et al.
European Journal of Immunology|December 3, 2005
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDOGerhard Wingender, Natalio Garbi, Beatrix Schumak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Cancer Cell|August 4, 2009
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsDamià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, et al.
Genes & Development|January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPaola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
Oncogene|July 12, 2018
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomasManfred Kunz, Henry Löffler-Wirth, Michael Dannemann, et al.
Nature|February 12, 2019
Author Correction: Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skinSimone L Park, Anthony Buzzai, Jai Rautela, et al.
Nature|January 2, 2019
Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skinSimone L Park, Anthony Buzzai, Jai Rautela, et al.
Pageof 14